Tzu-Ting Huang

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Venues

Cancer research

Nature communications

Cells

Cancers

National Cancer Institute

National Yang-Ming University School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute

United States

CRTA Postdoc Fellow

Education History

National Yang-Ming University School of Medicine

Taiwan

PHD :: Department and Institute of Pharmacology

Publications

Tzu-Ting Huang, Chih-Yuan Chiang, Jayakumar R Nair, Kelli M Wilson, Ken Cheng, Jung-Min Lee
AKT1 interacts with DHX9 to mitigate R-loop-induced replication stress in ovarian cancer. Cancer research (2024)
Kristen R Ibanez, Tzu-Ting Huang, Jung-Min Lee
Combination Therapy Approach to Overcome the Resistance to PI3K Pathway Inhibitors in Gynecological Cancers. Cells 13 (12) (2024)
Tzu-Ting Huang, Chih-Yuan Chiang, Jayakumar R Nair, Kelli M Wilson, Ken Cheng, Jung-Min Lee
AKT1 interacts with DHX9 to Mitigate R Loop-Induced Replication Stress in Ovarian Cancer. Cancer research 84 (6) (2024)
Kristen R Ibanez, Tzu-Ting Huang, Jung-Min Lee
Combination Therapy Approach to Overcome the Resistance to PI3K Pathway Inhibitors in Gynecological Cancers. Cells 13 (12) (2024)
Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)
Tzu-Ting Huang, Chih-Yuan Chiang, Jayakumar R Nair, Kelli M Wilson, Ken Cheng, Jung-Min Lee
AKT1 interacts with DHX9 to Mitigate R Loop-Induced Replication Stress in Ovarian Cancer. Cancer research 84 (6) (2024)
Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)
Tzu-Ting Huang, Chih-Yuan Chiang, Jayakumar R Nair, Kelli M Wilson, Ken Cheng, Jung-Min Lee
AKT1 interacts with DHX9 to Mitigate R Loop-Induced Replication Stress in Ovarian Cancer. Cancer research 84 (6) (2024)
Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)
Nitasha Gupta, Tzu-Ting Huang, Jayakumar R Nair, Daniel An, Grant Zurcher, Erika J Lampert, Ann McCoy, Ashley Cimino-Mathews, Elizabeth M Swisher, Marc R Radke, Christina M Lockwood, Jonathan B Reichel, Chih-Yuan Chiang, Kelli M Wilson, Ken Chih-Chien Cheng, Darryl Nousome, Jung-Min Lee
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA -mutant ovarian cancer. Science translational medicine 15 (701) (2023)
Tzu-Ting Huang, Ethan Brill, Jayakumar R Nair, Xiaohu Zhang, Kelli M Wilson, Lu Chen, Craig J Thomas, Jung-Min Lee
Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor-Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer. Cancer research 80 (23) (2020)
Chun-Yu Liu, Pei-Yi Chu, Chun-Teng Huang, Ji-Lin Chen, Hsiu-Ping Yang, Wan-Lun Wang, Ka-Yi Lau, Chia-Han Lee, Tien-Yun Lan, Tzu-Ting Huang, Po-Han Lin, Ming-Shen Dai, Ling-Ming Tseng
Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer Cells. Cancers 11 (1) (2019)
Chun-Yu Liu, Tzu-Ting Huang, Pei-Yi Chu, Chun-Teng Huang, Chia-Han Lee, Wan-Lun Wang, Ka-Yi Lau, Wen-Chun Tsai, Tzu-I Chao, Jung-Chen Su, Ming-Huang Chen, Chung-Wai Shiau, Ling-Ming Tseng, Kuen-Feng Chen
The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells. Experimental & molecular medicine 49 (8) (2017)

Tzu-Ting Huang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tzu-Ting Huang